Fig. 6: Docking patterns of valbenazine and deutetrabenazine interactions with specific core target proteins.

A Valbenazine-DRD1; (B) Valbenazine-DRD2; (C) Valbenazine-DRD3; (D) Valbenazine-MAOB; (E) Valbenazine-SLC6A3; (F) Valbenazine-SLC18A2; (G) Deutetrabenazine-DRD1; (H) Deutetrabenazine-DRD2; (I) Deutetrabenazine-MAOA; (J) Deutetrabenazine-MAOB; (K) Deutetrabenazine-SLC6A3; (L) Deutetrabenazine-SLC18A2.